Clinical Trial Update: Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature [NA]

View source ↗

Summary

This is a prospective, multicenter study evaluating the performance and safety of the Eversense Gemini System with a Flash Glucose Measurement feature; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Eversense Gemini System with Flash Glucose Measurement Feature

Snippet

Sponsor: Senseonics, Inc. | Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 1 | NA | Status: RECRUITING